- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Primary biliary cholangitis
- Meeting Date: July 2019
- Public Summary Document (PSD) July 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) July 2019 PBAC Meeting - (Word 181KB)
Obeticholic acid – July 2019
Obeticholic Acid: Tablet 5 mg, Tablet 10 mg; Ocaliva®
Last updated
1 November 2019